These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37141675)

  • 21. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
    van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
    Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations.
    Malter W; Eichler C; Hanstein B; Mallmann P; Holtschmidt J
    In Vivo; 2020; 34(3):1207-1213. PubMed ID: 32354911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
    Christenhusz A; den Dekker BM; van Dalen T; Jongen L; van der Schaaf MC; Alic L; Ten Haken B; Pijnappel RM; Dassen AE
    Breast Cancer Res Treat; 2023 Aug; 201(1):67-75. PubMed ID: 37322358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review.
    Tayeh S; Wazir U; Mokbel K
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of wire-guided and radio-guided occult lesion localization for non-palpable breast lesions: A systematic literature review and meta-analysis of current evidence.
    Kiruparan N; Kiruparan P; Debnath D
    Asian J Surg; 2022 Jan; 45(1):79-88. PubMed ID: 34479779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative histological diagnosis of breast cancer.
    Serpell JW; Johnson WR
    Aust N Z J Surg; 1997 Jun; 67(6):325-9. PubMed ID: 9193264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of radiofrequency identification tag accuracy using bronchoscopy with fluoroscopy and virtual navigation guidance before segmentectomy.
    Komatsu M; Miura K; Yamanaka M; Suzuki Y; Araki T; Goto N; Akahane J; Sonehara K; Matsuoka S; Eguchi T; Hamanaka K; Shimizu K; Yasuo M; Hanaoka M
    Surg Endosc; 2024 Sep; 38(9):5438-5445. PubMed ID: 39090201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Savi Scout® Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases.
    Kasem I; Mokbel K
    Anticancer Res; 2020 Jul; 40(7):3633-3643. PubMed ID: 32620602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound and mammography guided wire marking of non-palpable breast lesions: analysis of 741 cases.
    Köhler J; Krause B; Grunwald S; Thomas A; Köhler G; Schwesinger G; Schimming A; Jäger B; Paepke S; Ohlinger R
    Ultraschall Med; 2007 Jun; 28(3):283-90. PubMed ID: 17315109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioactive seed localisation of non-palpable lymph nodes - A feasibility study.
    Hassing CMS; Tvedskov TF; Kroman N; Klausen TL; Drejøe JB; Tvedskov JF; Lambine TL; Kledal H; Lelkaitis G; Langhans L
    Eur J Surg Oncol; 2018 May; 44(5):725-730. PubMed ID: 29545086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to go wireless? A 15-year single institution experience of radioisotope occult lesion localisation (ROLL) for impalpable breast lesions.
    Hawkins SC; Brown I; King P; El-Gammal M; Stepp K; Widdison S; Barta M; Jackson N; Drew P; English R; Ahmad S
    Eur J Surg Oncol; 2017 Jan; 43(1):62-67. PubMed ID: 27667335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.
    Follacchio GA; Monteleone F; Anibaldi P; De Vincentis G; Iacobelli S; Merola R; D'Orazi V; Monti M; Pasta V
    J Exp Clin Cancer Res; 2015 Oct; 34():113. PubMed ID: 26445493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of magnetic seed localisation of non-palpable breast lesions: pilot study in a Chinese population.
    Fung WY; Wong T; Chau CM; Yu ELM; Chan TS; Chan RLS; Yung AWT; Ma JKF
    Hong Kong Med J; 2020 Dec; 26(6):500-509. PubMed ID: 33303700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioguided localisation of non-palpable breast lesions and simultaneous sentinel lymph node mapping.
    Barros A; Cardoso MA; Sheng PY; Costa PA; Pelizon C
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1561-5. PubMed ID: 12458388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a Wireless Localization System for Nonpalpable Breast Lesions - Feasibility and Cost-effectiveness in Everyday Clinical Routine.
    Heindl F; Schulz-Wendtland R; Jud S; Erber R; Hack CC; Preuss C; Behrens A; Pöschke P; Emons J
    In Vivo; 2022; 36(5):2342-2349. PubMed ID: 36099117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical review of 215 cases of non-palpable mammary lesions].
    Pastore G; Marano P; Romani M; Costantini M; Belli P
    Radiol Med; 1999 May; 97(5):344-8. PubMed ID: 10432964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer.
    Ramos M; Díaz JC; Ramos T; Ruano R; Aparicio M; Sancho M; González-Orús JM
    Breast; 2013 Aug; 22(4):520-4. PubMed ID: 23110817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.